ACM
LLY icon

ADAR1 Capital Management’s Eli Lilly LLY Stock Holding History

ADAR1 Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,060
Closed -$4.65M – 317
2026
Q1 		$4.65M Buy
+5,060
New +$5.13M 0.27% 81
2025
Q4 		– Sell
-1,000
Closed -$763K – 283
2025
Q3 		$763K Buy
1,000
+500
+100% +$372K 0.07% 111
2025
Q2 		$390K Sell
500
-100
-17% -$77.7K 0.06% 128
2025
Q1 		$496K Sell
600
-750
-56% -$624K 0.09% 104
2024
Q4 		$1.04M Buy
1,350
+200
+17% +$166K 0.21% 74
2024
Q3 		$1.02M Buy
+1,150
New +$1.03M 0.17% 77
2024
Q2 		– Sell
-1,865
Closed -$1.45M – 300
2024
Q1 		$1.45M Buy
+1,865
New +$1.33M 0.33% 53

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ADAR1 Capital Management's LLY Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 5,060 shares — an estimated $4.65M sold.

ADAR1 Capital Management first reported a position in LLY in Q1 2024 and held it in 7 quarters. The position peaked at $4.65M in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 5,060 Eli Lilly shares in Q2 2026, an estimated $4.65M.
  • ADAR1 Capital Management first reported a position in Eli Lilly in Q1 2024 and held it in 7 quarters.
  • ADAR1 Capital Management's Eli Lilly position peaked at $4.65M in Q1 2026.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.